Literature DB >> 16444456

Hypertension, antihypertensive therapy, and erectile dysfunction.

Athanasios G Papatsoris1, Panagiotis G Korantzopoulos.   

Abstract

Erectile dysfunction represents a common problem in the male hypertensive population. Both erectile dysfunction and hypertension share common pathophysiologic pathways such as atherosclerosis and endothelial dysfunction. Furthermore, traditional cardiovascular risk factors affect both conditions. Notably, several antihypertensive medications seem to adversely affect erectile function whereas others may exert neutral or even favorable effects. Thus, the regular and meticulous clinical evaluation of hypertensive patients, as well as individualization of anti-hypertensive therapy, are important steps in the effective management of such patients. In addition, the administration of phosphodiesterase-5 inhibitors or apomorphine has excellent efficacy and safety profile in hypertensive patients irrespective of taking or not taking antihypertensive medications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16444456     DOI: 10.1177/000331970605700107

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  10 in total

Review 1.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Taking the stress out of treating erectile dysfunction.

Authors:  Andries J Muller; Loren Regier; Brent Jensen
Journal:  Can Fam Physician       Date:  2010-09       Impact factor: 3.275

3.  New insights into hypertension-associated erectile dysfunction.

Authors:  Kenia Pedrosa Nunes; Hicham Labazi; R Clinton Webb
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-03       Impact factor: 2.894

4.  Managing erectile dysfunction in hypertensive patients.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04-22       Impact factor: 3.738

5.  A Review of the Pathophysiology and Novel Treatments for Erectile Dysfunction.

Authors:  George F Lasker; Jason H Maley; Philip J Kadowitz
Journal:  Adv Pharmacol Sci       Date:  2010

Review 6.  Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension.

Authors:  Steven G Chrysant
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

Review 7.  Adverse effects of drug therapies on male and female sexual function.

Authors:  Th Stadler; M Bader; S Uckert; M Staehler; A Becker; C G Stief
Journal:  World J Urol       Date:  2006-12       Impact factor: 3.661

8.  Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.

Authors:  Elisabet Ekman; Staffan Hägg; Anders Sundström; Viktoria Werkström
Journal:  Drug Healthc Patient Saf       Date:  2010-03-29

9.  Blood Oxygen Accumulation Distribution Area Index Is Associated With Erectile Dysfunction in Patients With Sleep Apnea-Results From a Cross-sectional Study.

Authors:  Wenzhong Zheng; Xiang Chen; Jingwen Huang; Shengxiong Zhang; Tao Chen; Liu Zhang; Xianxin Li; Qingyun Li; Jican Dai
Journal:  Sex Med       Date:  2020-01-31       Impact factor: 2.491

Review 10.  The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-07       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.